|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 534.00 SEK | +0.75% |
|
+1.04% | -2.73% |
| 09-15 | Odin Small Cap rose 4.15% in August, 16 holdings beat expectations | FW |
| 09-09 | PriorNilsson Evolve Global rose 0.49 percent in August, increased exposure to Kitron and Scanfil | FW |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 7,997 | - | - |
| Change | - | 78.07% | -6.99% | -3.39% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 8,080 | 7,842 | 7,601 |
| Change | - | 83.61% | -8.9% | -3.34% | -2.95% | -3.07% |
| P/E | 29.1x | 42.9x | - | 31.5x | 26.8x | 23.6x |
| PBR | - | 6.95x | - | 4.66x | 3.97x | 3.4x |
| PEG | - | 2.1x | - | - | 1.5x | 1.8x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.33x | 2.98x | 2.73x |
| EV / Revenue | - | 5.08x | 3.97x | 3.37x | 2.92x | 2.6x |
| EV / EBITDA | - | 23.7x | 18.3x | 14.7x | 12.4x | 11x |
| EV / EBIT | - | 33.7x | 27.6x | 21.8x | 17.9x | 15.9x |
| EV / FCF | - | 28.8x | 26.4x | 43.7x | 21.8x | 18.5x |
| FCF Yield | - | 3.47% | 3.79% | 2.29% | 4.58% | 5.41% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 16.97 | 19.95 | 22.62 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,398 | 2,686 | 2,927 |
| EBITDA 1 | - | 387.7 | 456.3 | 551.5 | 632 | 694 |
| EBIT 1 | - | 272.3 | 302.9 | 370 | 437 | 479.5 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 258 | 319 | 356 |
| Net Debt 1 | - | 276.5 | 81.3 | 83 | -155 | -395.5 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 534.00 | 534.00 | 534.00 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 14,976 | - | - |
| Announcement Date | 1/31/24 | 1/31/25 | 2/5/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.37x | 14.65x | - | 811M | |
| 24.54x | 10.63x | 17.63x | 1.94% | 35.56B | |
| 15.06x | 7.79x | 12.61x | 7.58% | 19.18B | |
| 16.64x | 7.44x | 12.14x | 3.97% | 15.12B | |
| 23.54x | 4.63x | 8.05x | 3.21% | 3.62B | |
| 7.81x | 0.93x | 5.04x | 4.8% | 1.25B | |
| 12.6x | 14.05x | 13.4x | 5.32% | 932M | |
| 8.43x | 7.68x | 8.26x | 6.4% | 770M | |
| 7.03x | 7x | 25.31x | 4.88% | 573M | |
| Average | 14.46x | 7.06x | 13.01x | 4.76% | 8.65B | |
| Weighted average by Cap. | 19.87x | 8.79x | 14.56x | 3.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
